Most men who come to us about low testosterone expect the same answer they have read everywhere: a gel or an injection to replace what the body is missing. Sometimes that is the right call. But there is a question that too often gets skipped at the start, and it matters most for younger men and anyone who might want children someday. Will this treatment cost me my fertility? For standard testosterone therapy, the honest answer is that it usually can. The good news is that it is not the only option. Clomiphene, its refined cousin enclomiphene, and human chorionic gonadotropin (hCG) can raise your own testosterone while keeping your fertility intact.
If you have read our overview of testosterone replacement therapy or the signs of low testosterone, you already know that a real diagnosis comes before any treatment. This post picks up from there and explains a set of medications that many men are never told about.
Why standard testosterone therapy can shut down fertility
When you take testosterone from the outside, your brain notices there is plenty around and stops sending the signal that keeps your testes working. Two of those signals, LH and FSH, fall to near zero. FSH is the one that drives sperm production, so sperm counts drop, sometimes to none at all. The Endocrine Society and the American Urological Association both flag this clearly and advise against starting standard testosterone in men who want to father children (https://pubmed.ncbi.nlm.nih.gov/29562364/).
Counts often recover after stopping, but recovery can take anywhere from a few months to well over a year, and it is not guaranteed. That is a real tradeoff to weigh before, not after, you start a protocol. The medications below work differently, and that difference is the whole point.
The hormone axis, in plain terms
Testosterone is the last step in a chain of commands that starts in your brain. The hypothalamus releases a signal that tells the pituitary gland to release two messengers: LH and FSH. LH tells the testes to make testosterone. FSH tells them to make sperm. This chain has a name, the hypothalamic-pituitary-gonadal axis, and it runs on a thermostat. When testosterone and estrogen are high, the brain dials the signal down. When they are low, it dials the signal up.
This is why where the problem sits changes everything. In secondary hypogonadism, the testes work fine but the brain is not sending enough signal, so LH and FSH are low or unhelpfully normal. In primary hypogonadism, the signal is loud but the testes cannot answer, so LH and FSH are already high. Clomiphene, enclomiphene, and hCG only help when the testes are still capable of responding. That is the single most important thing to sort out before choosing any of them.
How clomiphene and enclomiphene raise your own testosterone
Clomiphene is a medication that blocks estrogen receptors in the brain. The brain reads this as low estrogen and responds by turning the signal up, which raises both LH and FSH. More LH means more of your own testosterone. More FSH means sperm production keeps running. Because clomiphene works at the top of the axis rather than replacing testosterone at the bottom, it lifts hormones the body would have made itself.
The evidence here is solid and not new. A long-term study in the Journal of Urology followed men on clomiphene for a median of about three years and found most held normal testosterone with a stable safety profile (https://pubmed.ncbi.nlm.nih.gov/31216250/). A separate long-term series reported the same durability (https://pubmed.ncbi.nlm.nih.gov/22458540/), and a 2022 systematic review and meta-analysis confirmed that clomiphene reliably raises testosterone in men with secondary hypogonadism (https://pubmed.ncbi.nlm.nih.gov/34933414/).
Enclomiphene is the refined version of the same idea. Clomiphene is actually a blend of two forms, and enclomiphene is the one that does most of the testosterone-raising work, without the longer-lingering form that can drive some side effects. In studies of men with secondary hypogonadism, enclomiphene raised testosterone by increasing LH and FSH while keeping sperm counts intact, in direct contrast to testosterone gel, which raised testosterone but suppressed sperm (https://pubmed.ncbi.nlm.nih.gov/23530575/). A phase II trial showed it restored testosterone while preventing the drop in sperm count seen with topical testosterone (https://pubmed.ncbi.nlm.nih.gov/25044085/), and a clinical review summarizes why its cleaner profile makes it an appealing choice (https://pubmed.ncbi.nlm.nih.gov/27337642/).
Where hCG fits differently
hCG takes the opposite route. Instead of prompting the brain, it acts directly at the testes because it closely resembles LH and binds the same receptors. In effect, it delivers the signal the pituitary was failing to send. Testosterone rises as a result. But because hCG bypasses the brain entirely, it does not raise FSH. For a man whose main goal is sperm production, that is a meaningful limitation, which is why hCG is sometimes paired with FSH or used alongside a medication like clomiphene.
hCG is also the tool most often added to standard testosterone therapy to keep the testes active and preserve their size, since exogenous testosterone otherwise switches them off. A recent cohort study comparing clomiphene and hCG head to head found both raised testosterone effectively in secondary hypogonadism, but they left different hormonal footprints, with clomiphene producing the fuller LH and FSH response and hCG tending to push estradiol higher relative to testosterone in some men (https://pubmed.ncbi.nlm.nih.gov/42402873/). Neither is universally better. The right choice depends on where your axis is struggling and what your goals are.
Who is a candidate, and who is not
The best candidate is a man with secondary hypogonadism: symptoms of low testosterone, a genuinely low level confirmed on more than one morning blood draw, low or inappropriately normal LH and FSH, and no reversible cause hiding underneath. Fertility being a current or future priority moves these medications to the front of the line.
They are not the answer for everyone. If your LH and FSH are already high, your testes have stopped responding, and pushing the axis harder will not help. Men with a history of a hormone-sensitive cancer, certain eye conditions, or an untreated pituitary tumor need a careful workup first. And clomiphene carries one warning worth repeating: any change in your vision means stop the medication and call us. Mood changes and a rise in estradiol are also possible, which is why we check estradiol alongside testosterone rather than testosterone alone.
How we approach this at NoMi Beach Health
When a man comes to us with low libido, real fatigue, softer erections, or loss of muscle, we do not start with a prescription. We start with a workup: two morning testosterone draws on separate days, plus LH, FSH, estradiol, prolactin, a thyroid panel, a blood count, and PSA when age warrants it. We look hard for reversible causes such as poor sleep, weight, certain medications, or a high prolactin, because fixing those can restore testosterone with no medication at all.
If the picture points to secondary hypogonadism and fertility matters, clomiphene, enclomiphene, or hCG goes to the top of the conversation before standard testosterone is even on the table. If you are already on testosterone from somewhere else and want to protect your fertility or add hCG, that is a different plan with a different answer. Either way, we recheck labs at six weeks and three months, adjust based on data rather than assumptions, and tell you plainly if something is not working. For a wider view of men's hormonal health across your 30s, 40s, and beyond, our guide on concierge men's health after 35 is a good companion read.
If low testosterone is on your mind, or you have been on a protocol elsewhere and want a second opinion built on your actual labs, we would like to talk. You can learn more and book a new-patient visit on our men's health page, or call us at (786) 744-5152. We will look at the full picture, explain what the evidence supports, and build a plan that protects the parts of your health you are not willing to trade away.
Frequently Asked Questions
- Does testosterone therapy make you infertile?
- For most men, yes, at least while they are on it. Testosterone from a gel or injection tells the brain to stop signaling the testes, which shuts down sperm production. Sperm counts usually recover after stopping, but recovery can take months to more than a year and is not guaranteed. If fertility matters now or later, this is worth discussing before you start.
- What is the difference between clomiphene and enclomiphene?
- Enclomiphene is one of the two active pieces of clomiphene. Clomiphene is a mix of two forms (enclomiphene and zuclomiphene); enclomiphene is the isolated form that does most of the testosterone-raising work with a cleaner side-effect profile. Both raise LH and FSH and preserve sperm production (https://pubmed.ncbi.nlm.nih.gov/23875626/).
- How is clomiphene different from hCG?
- Clomiphene works at the brain, prompting the pituitary to release more LH and FSH so the testes make their own testosterone. hCG skips the brain and directly stimulates the testes by imitating LH. Clomiphene raises FSH (which supports sperm); hCG alone does not.
- How long before clomiphene raises my testosterone?
- Many men see measurable rises within four to six weeks, with the full effect judged around three months. We recheck labs at six weeks and three months before changing anything, because response depends on your baseline LH and FSH and the underlying cause.
- What are the main side effects of clomiphene in men?
- The most important is any change in vision, which means stopping the medication and calling us right away. Mood changes and a rise in estradiol (which can cause breast tenderness) are also possible. We monitor estradiol alongside testosterone so we can adjust before symptoms build.
- Who is not a good candidate for these medications?
- Men with primary hypogonadism, where the testes themselves have failed and LH and FSH are already high. Stimulating the axis harder will not help. Men with certain vision conditions, hormone-sensitive cancers, or an untreated pituitary tumor also need careful evaluation first.
- Does insurance cover clomiphene or hCG for low testosterone in men?
- Often not. Clomiphene is FDA-approved for female infertility, so its use in men is off-label and coverage is inconsistent. We are a cash-pay practice and are clear about cost at the intake visit so there are no surprises.
Sources
- Clift AK, Johnson H, et al. Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study. World J Mens Health (2026).
- Wiehle RD, Cunningham GR, Pitteloud N, et al. Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. BJU Int (2013);112(8):1188-1200.
- Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral Enclomiphene Citrate Stimulates the Endogenous Production of Testosterone and Sperm Counts in Men with Low Testosterone: Comparison with Testosterone Gel. J Sex Med (2013);10(6):1628-1635.
- Wiehle RD, Fontenot GK, et al. Enclomiphene Citrate Stimulates Testosterone Production While Preventing Oligospermia: A Randomized Phase II Clinical Trial Comparing Topical Testosterone. Fertil Steril (2014);102(3):720-727.
- Rodriguez KM, Pastuszak AW, Lipshultz LI. Enclomiphene Citrate for the Treatment of Secondary Male Hypogonadism. Expert Opin Pharmacother (2016);17(11):1561-1567.
- Krzastek SC, Sharma D, et al. Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism. J Urol (2019);202(5):1029-1035.
- Moskovic DJ, Katz DJ, Akhavan A, et al. Clomiphene Citrate Is Safe and Effective for Long-Term Management of Hypogonadism. BJU Int (2012);110(10):1524-1528.
- Huijben M, Lock MTWT, et al. Clomiphene Citrate for Men with Hypogonadism: A Systematic Review and Meta-Analysis. Andrology (2022);10(3):451-469.
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2018);103(5):1715-1744.
- American Urological Association. Testosterone Deficiency Guideline (2018, amended 2024).



